Orizuru Therapeutics, Inc.
PrivateLast Round
Series B
Feb 29, 2024
Total Funding Raised
$76.62M
Company Overview
Orizuru Therapeutics, Inc. is a biotechnology company that develops regenerative medical products through cell therapy and provides services to support drug discovery research using induced pluripotent stem cell (iPSC) technology.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Orizuru Therapeutics, Inc. Comparables
Compare Orizuru Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| iPS Bio, Inc. | 82% | |
| Rege Nephro Co., Ltd. | 82% | |
| iHeart Japan Corporation | 79% | |
Orizuru Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Feb 29, 2024 | ||||
| Series A | Aug 10, 2021 | ||||
| Seed | Aug 10, 2021 |
Key People
Founding team and executive leadership
Orizuru Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Sumitomo Mitsui Trust Bank | Series A |
| 日本ベンチャーキャピタル株式会社 | Series A |
| MUFG Bank | Series B, Series A |
| Sumitomo Mitsui Finance & Leasing | Series A |
| Japan Growth Capital Investment Corporation | Series B |
| Kyoto University Innovation Capital | Series B, Seed |
| SMBC Venture Capital | Series B, Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 29, 2024
$22M round led by Japan Growth Capital Investment Corporation.
- Aug 10, 2021
$55M round with MUFG Bank and SMBC Venture Capital.
Orizuru Therapeutics, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Orizuru Therapeutics, Inc.'s valuation, stock price, and market status.